Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide versus metformin for beta-cell protection in young adults with newly diagnosed type 2 diabetes
ChiCTR1800018008Phase 4Completed
- Sponsor
- Xiamen University Affiliated Zhongshan Hospital
- Start
- Jan 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of liraglutide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Xiamen University Affiliated Zhongshan Hospital. Primary endpoints: Proinsulin, 8-hydroxy-2'-deoxyguanosine and 3 more. Started Jan 2015; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1800018008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800018008.